Unknown

Dataset Information

0

Repurposing glucocorticoids as adjuvant reagents for immune checkpoint inhibitors in solid cancers.

ABSTRACT:

SUBMITTER: Yu Y 

PROVIDER: S-EPMC8610151 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Update on immune checkpoint inhibitors in gynecological cancers.
| S-EPMC5323287 | biostudies-literature
Unknown Current Status of Immune Checkpoint Inhibitors in Gastrointestinal Cancers.
| S-EPMC5479252 | biostudies-literature
Unknown Biomarkers for response to immune checkpoint inhibitors in gastrointestinal cancers
| S-EPMC8790411 | biostudies-literature
Unknown Immune checkpoint inhibitors in the treatment of virus-associated cancers.
| S-EPMC6558794 | biostudies-literature
Unknown How Can Immune Checkpoint Inhibitors Cause Hyperprogression in Solid Tumors?
| S-EPMC7098964 | biostudies-literature
Unknown Immune Checkpoint Inhibitors in Pediatric Solid Tumors: Status in 2018.
| S-EPMC6292483 | biostudies-literature
Unknown DNA Mismatch Repair Deficiency and Immune Checkpoint Inhibitors in Gastrointestinal Cancers.
| S-EPMC6409193 | biostudies-literature
Unknown Retreatment with immune checkpoint inhibitors in solid tumors: a systematic review.
| S-EPMC7705192 | biostudies-literature
Unknown Clinical outcomes of solid organ transplant recipients with metastatic cancers who are treated with immune checkpoint inhibitors: A single-center analysis.
| S-EPMC8772343 | biostudies-literature
Unknown Immune Checkpoint Inhibitors for Genitourinary Cancers: Treatment Indications, Investigational Approaches and Biomarkers.
| S-EPMC8582522 | biostudies-literature